Results 191 to 200 of about 9,892 (240)

Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes. [PDF]

Kidney Int Rep
De Rosa LI, Catania M, Kola K, Paolisi M, Bianca P, Manunta P, Vezzoli G, Sciarrone Alibrandi MT.   +7 more
europepmc   +1 more source

Utility of tolvaptan sodium phosphate for refractory fluid retention in post-transplant sinusoidal obstruction syndrome. [PDF]

Int J Hematol
Akahane K, Kasai S, Tamai M, Sugita Y, Oshiro H, Goi K, Inukai T.   +6 more
europepmc   +1 more source

Effectiveness of Urea and Tolvaptan in the Treatment of Hypotonic Hyponatremia. [PDF]

J Clin Med
Delgado-Cuesta J, Escorial-Moya C, Vallejo-Vaz AJ, Santos-Ramos B, Varela JM, Calderón EJ, Medrano FJ.   +6 more
europepmc   +1 more source

Real-World Tolvaptan Use in Autosomal Dominant Polycystic Kidney Disease: Insights from Two US Medical Centers. [PDF]

Kidney360
Rao V, Ammar S, Alshorman A, Fravel M, McGreal KA, Winklhofer FT, Noureddine L, Jalal DI, Yu ASL, Mustafa RA.   +9 more
europepmc   +1 more source

Syndrome of Inappropriate Anti-diuretic Hormone (SIADH) in Non-small Cell Lung Cancer (NSCLC) Following Agent Orange Exposure: A Case Report. [PDF]

Cureus
Ball JC, Rutt GJ, Ballantyne M.
europepmc   +1 more source

Internal Medicine (2) [PDF]

, 2017
上野 博志, 傍島 光男, 坂本 有, 城宝 秀司, 小池 勤, 平井 忠和, 福田 信之, 絹川 弘一郎, 西田 邦洋, 野手 姫代美   +9 more
core   +1 more source

Aberrant activation of IL-6/JAK/STAT3/FOSL1 signaling induces renal abnormalities in a Xenopus model of Joubert syndrome-related disorders. [PDF]

J Biol Chem
Uuganbayar U, Ninomiya H, Shimada IS, Yamada C, Kanie M, Kawai S, Asai T, Miyoshi-Akiyama T, Itoh M, Hashimoto Y, Kato Y.   +10 more
europepmc   +1 more source

Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review. [PDF]

Ren Fail
Borghol AH, Azooz M, Bou Antoun MT, Souvalian L, Shami B, Mina J, Munairdjy Debeh FG, Ghanem A, Sandouk H, Rangarajan V, Hanna D, Naranjo CD, Drexler Y, Norouzi S, Noruzi A, Salih M, Klett DE, Porter IE, Dahl NK, Chebib FT.   +19 more
europepmc   +1 more source

Dual paraneoplastic syndrome with prostate cancer: A case of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) and humoral hypercalcemia of malignancy (HHM). [PDF]

Urol Case Rep
Abe J, Muranaka T, Kunishima Y.
europepmc   +1 more source

Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence. [PDF]

Curr Issues Mol Biol
Maciejczyk A, Niemczyk M.
europepmc   +1 more source